However, Lynch syndrome was characterized by increased CD8+ T cells but decreased PD-L1+ macrophages, suggesting that patients with Lynch syndrome EC was less responsive to single-agent anti-PD-L1 or anti-PD-1 therapies [20]. This evidence concerns the gene CD274 and Lynch syndrome.